Posts

GDPR – insight to data protection updates for clinical trials

Considering the recent Regulation (EU) 2016/579 (GDPR) on the protection of natural persons with regarding the processing of personal data and on the free movement of such data, many companies, within or outside the European Union, are challenged to implement specific data protection requirements in their own businesses and day to day activity.

CTA FOCUS proudly announces opening of its subsidiary in Moscow, Russia.

Bucharest – Romania, 10th of August 2018

Clinical Trial Agreements FOCUS (CTA FOCUS) proudly announces opening of its subsidiary in Moscow, Russia.

Achieving this milestone CTA FOCUS expanded its presence to the biggest country in the World with over 1600 experienced sites accredited by the Ministry of Health for clinical trials conduct.

The company is now based in Romania with its headquarter in Bucharest, and offices in Kiev, Ukraine in Malaga, Spain and starting from 10th of August will owe the 4th headquarter in one of most promising capitals in the world.

CTA FOCUS announces the opening of its new subsidiary in Kiev, Ukraine

Bucharest - Romania, 16th of July 2018

Clinical Trial Agreements FOCUS (CTA FOCUS), a Romanian based company with global clinical research services, has announced today the opening of its new subsidiary in Kiev, Ukraine.

In addition to its current headquarters, located in Bucharest, Romania and Malaga, Spain, the company will have, as of July 1st, a new headquarter in one of Europe’s most promising capitals.

The Ukrainian division, registered at 17, Savrasova Street, 03110 - Kiev, Ukraine, will be focused mainly on clinical trials negotiation, its secondary focus being on site payments.

Global clinical trials alliance between CTA Focus and Astracrux

Starting this month, June 2018 CTA Focus will cover worldwide clinical trials negotiation based on new strategic alliance with AstraCrux Clinical Trail and Consulting Inc.

Clinical Trial Agreements FOCUS (CTA FOCUS), a Romanian based company with global clinical research services has announced today their strategic alliance with AstraCrux Clinical Trail and Consulting Inc., a Taiwan based company specialized in clinical trial negotiation providing as well as providing medical science consulting, including product development strategies and clinical trial planning and design, as well as specialist training.

CTA FOCUS and CTC announce strategic alliance

We have had a strong march into 2018 here at CTA FOCUS.

We would like to thank our clients and collaborators for their ongoing support and appreciation.

Amongst few of the changes that took place within our organization, we would like to mention establishing a new location for our Romanian headquarters, creating and Alliance with CTC and sponsoring few events that we will exhibit with this year in EU and the USA.

New approach for Contract Negotiations in Clinical Trials

The complex business environment of the 21st century would not be possible without the existence of contract law. Simply put: contracts make doing business possible, furthermore clinical trial agreements can make the difference between a successful or a challenged clinical study. CTA Focus wants to bring quality back to study-startup, which is why we have […]

CTA Focus: Quality Contract Negotiations in Clinical Trials

CTA Focus is a company focusing strictly on negotiating clinical trial agreements. Led by professionals with vast hands-on experience in both CROs and clinical trial Sponsors’ legal departments, CTA Focus an international contracting.

Solid facts and figures confirm CTA Focus’ reliability - our company guarantees significant experience in negotiating in over 57 countries throughout the world (EMEA, North America and South America), has an international team of 21 permanent specialists and 25 languages are spoken by the team.